title: [The choice of pacing sites: should we change our practice?].
abstract: For the past 45 years the sites used for elective pacing have been the apex of the right ventricle and the right atrium. Although the initial objective of pacing was the "simple" correction of a conduction disorder, a more recent evolution has been to achieve a favourable haemodynamic effect, considering left ventricular filling and synchronisation of ventricular contraction as essential. Demonstration of the benefit in terms of survival brought about by pacing in atrioventricular block has not required large trials. However, it is possible that this improvement in morbidity and mortality is in part offset by the altered haemodynamics due to pacing at the right ventricular apex. At the atrial level, the prevention of AF is the holy grail of atrial pacing, but is far from being attained, perhaps because the physiopathological bases are not clear and have not really been demonstrated, casting doubt on the final objective. The choice of pacing site is essential in this context, as much in the atrium as in the ventricle. The current problem regarding this choice is the same as for all medical treatment, where the risk/benefit ratio is evaluated: if the usual sites are potentially deleterious, is it possible to continue using them or is it necessary to change implantation practices, and what level of proof is needed?
authors.affiliation: Département de Rythmologie, Centre Cardiologique du Nord, Saint-Denis. o.piot@ccncardio.com
authors.forename: O
authors.initials: O
authors.lastname: Piot
authors.forename: X
authors.initials: X
authors.lastname: Copie
authors.forename: G
authors.initials: G
authors.lastname: Lascault
authors.forename: O
authors.initials: O
authors.lastname: Paziaud
mesh_terms: D001281:Atrial Fibrillation / Q000517:prevention & control*; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D006352:Heart Ventricles; D006801:Humans; D018487:Ventricular Dysfunction, Left / Q000628:therapy*